A phase I/II study of fixed-dose-rate gemcitabine and S-1 with concurrent radiotherapy for locally advanced pancreatic cancer.
Goji T, Kimura T, Miyamoto H, Takehara M, Kagemoto K, Okada Y, Okazaki J, Takaoka Y, Miyamoto Y, Mitsui Y, Matsumoto S, Sueuchi T, Tanaka K, Fujino Y, Takaoka T, Kitamura S, Okamoto K, Kimura M, Sogabe M, Muguruma N, Okahisa T, Sato Y, Sagawa T, Fujikawa K, Sato Y, Ikushima H, Takayama T.
Goji T, et al. Among authors: kimura m, kimura t.
Cancer Chemother Pharmacol. 2015 Sep;76(3):615-20. doi: 10.1007/s00280-015-2835-3. Epub 2015 Jul 29.
Cancer Chemother Pharmacol. 2015.
PMID: 26220846
Clinical Trial.